Expression levels of lysosome-related genes in HFD-fed flies and control group. by Tong Yue (6033305)

Baseline Characteristics of Study Participants. by Swati M. Surkar (8399427)

“…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …”

Raw and processed data files. by Swati M. Surkar (8399427)

“…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …”

Transient suppression of autophagy in neurons impairs ITM. by Tong Yue (6033305)

Risk of bias summary. by Duc Tran Quang (20564967)

“…The effectiveness of the TRE was found to vary across health conditions, with modest weight loss observed in healthy individuals (pooled effect size -1.04 Kg, 95% CI: -1.42 to -0.65) and more significant weight reduction seen in participants with chronic diseases (pooled effect size -3.33 Kg, 95% CI: -5.05 to -1.62) and overweight/obesity (pooled effect size -4.21 Kg, 95% CI: -5.23 to -3.10). …”

Criteria for study selection. by Duc Tran Quang (20564967)

“…The effectiveness of the TRE was found to vary across health conditions, with modest weight loss observed in healthy individuals (pooled effect size -1.04 Kg, 95% CI: -1.42 to -0.65) and more significant weight reduction seen in participants with chronic diseases (pooled effect size -3.33 Kg, 95% CI: -5.05 to -1.62) and overweight/obesity (pooled effect size -4.21 Kg, 95% CI: -5.23 to -3.10). …”

Number of visits per clinic type, 2013-2015. by Jacob Dreiher (14856863)

“…During PE, statistically significant longer waiting times were found for surgery (+1.0 day) and imaging (+1.1 days), while a 2.4 days decrease was noted in pediatrics, controlled for age, sex, ethnicity and the daily number of visits. …”

Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i> by Vidya G. Bettada (22208808)

“…Human and rat glioblastoma cell lines U-87 MG and C6, respectively; which were exposed to vitamin D3 demonstrated a statistically significant reduction in viable cells with increasing time and treatment concentration. 1H. …”

HFD impairs autophagic activity in fly brains. by Tong Yue (6033305)

Effect of Oxamate, LBP, or their combination on partial glycolysis metabolites in A549 and NCL-H1975 cells after 24 hours of treatment. by Siyu Yuan (7425719)

Subjects:

LDHA expression is an independent prognostic factor for the overall survival of LUAD patients. by Siyu Yuan (7425719)

Subjects:

Knockdown of LDHA reduced cell viability and LDH activity in A549 and NCL-H1975 cells, enhancing chemotherapy sensitivity to LBP. by Siyu Yuan (7425719)

Subjects:

Oxamate reduces cell viability, LDHA expression, and LDH activity in A549 and NCL-H1975 cells, enhancing the cytotoxic effect of LBP. by Siyu Yuan (7425719)

Subjects:

High expression of LDHA in LUAD is associated with poor prognosis. by Siyu Yuan (7425719)

Subjects:

Supplementing NAD+ counters the effects of Oxamate on metabolism and chemotherapy sensitivity. by Siyu Yuan (7425719)

Subjects:

Analysis of the correlation between LDHA expression and clinical characteristics. by Siyu Yuan (7425719)

Subjects:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”